Kunwha Pharmaceutical will complete the takeover of Dream Pharma for KRW 194.5 billion
Kunwha Pharmaceutical will complete taking over Dream Pharma by this December.
Kunwha Pharmaceutical said through the public announcement of prospectus “It is expected to purchase stocks of the divided created pharmaceutical corporation of Dream Pharma,currently owned by Hanwha Chemical,for KRW ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
